Publications by authors named "Shamool Fatima"

Claim this Profile
S
Synthesis of the chromone-thiosemicarbazone scaffold as promising α-glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design.
Rima D Alharthy, Sana Khalid, Shamool Fatima, Saeed Ullah, Ajmal Khan

Arch Pharm (Weinheim)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation, and molecular modelling of substituted thiazolyl thiourea derivatives: A new class of prolyl oligopeptidase inhibitors.
Saira Naseem, Angelo Oneto, Saeed Ullah, Shamool Fatima, Suraj N Mali

Int J Biol Macromol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbonylbis(hydrazine-1-carbothioamide) derivatives as a new class of α-glucosidase inhibitors and their mechanistic insights via molecular docking and dynamic simulations.
Saira Naseem, Shamool Fatima, Saeed Ullah, Ajmal Khan, Suraj N Mali

Arch Pharm (Weinheim)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
Rabia Basri, Shamool Fatima, Saquib Jalil, Aqeel Imran, Noor Fatima

Arch Pharm (Weinheim)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease.
Saira Naseem, Ahmed Temirak, Aqeel Imran, Saquib Jalil, Shamool Fatima

RSC Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis